FDA approves trial for wearable artificial kidney

February 10 2014

ATLANTA — The U.S. Food & Drug Administration has approved the start of the first human clinical trials in the United States for the wearable artificial kidney designed by Beverly Hills, Calif.-based Blood Purification Technologies Inc. The announcement was made by Victor Gura, MD, during the opening session on Sunday of the Annual Dialysis Conference taking place in Atlanta.

The device was one of three products related to end-stage renal disease that were awarded a special fast-track to market status in April 2012. The program, called Innovation Pathway, is a new system designed to help medical devices reach patients in a safe, timely, and collaborative manner. An implantable Renal Assist Device (iRAD) being developed by the University of California, San Francisco, and a Hemoaccess Valve System (HVS) designed by Greenville, S.C.-based CreatiVasc Medical were also awarded FDA fast track status

Original article: http://www.nephrologynews.com/articles/110030-fda-approves-trial-for-wearable-artificial-kidney

Recent News

Simon battles through the rain to raise over £2300 as others raise £1000 more
October 5 2020
Share you experience - Announcing The 2020 National Kidney Patient Survey - Kidney PREM
September 22 2020
Second online patient information meeting notes
September 20 2020
Have you shared your decision?
September 14 2020
In memory of John Roberts - former Chair & Honorary Secretary of SGKPA
September 7 2020

Join Us

Register with us, become a member and subscribe to our newsletters including the latest on the impact of coronavirus for patients at St George’s Hospital.